Adaptive Biotechnologies Corp
NASDAQ:ADPT
Adaptive Biotechnologies Corp
Net Issuance of Common Stock
Adaptive Biotechnologies Corp
Net Issuance of Common Stock Peer Comparison
Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors
Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Adaptive Biotechnologies Corp
NASDAQ:ADPT
|
Net Issuance of Common Stock
$1.6m
|
CAGR 3-Years
-83%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Net Issuance of Common Stock
-$3B
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-52%
|
CAGR 10-Years
N/A
|
|
Danaher Corp
NYSE:DHR
|
Net Issuance of Common Stock
$101m
|
CAGR 3-Years
-69%
|
CAGR 5-Years
-50%
|
CAGR 10-Years
-4%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Net Issuance of Common Stock
-$852.9m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-11%
|
|
Agilent Technologies Inc
NYSE:A
|
Net Issuance of Common Stock
-$434m
|
CAGR 3-Years
15%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
5%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Net Issuance of Common Stock
-$1.1B
|
CAGR 3-Years
-29%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
See Also
What is Adaptive Biotechnologies Corp's Net Issuance of Common Stock?
Net Issuance of Common Stock
1.6m
USD
Based on the financial report for Mar 31, 2024, Adaptive Biotechnologies Corp's Net Issuance of Common Stock amounts to 1.6m USD.
What is Adaptive Biotechnologies Corp's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 5Y
12%
Over the last year, the Net Issuance of Common Stock growth was -73%. The average annual Net Issuance of Common Stock growth rates for Adaptive Biotechnologies Corp have been -83% over the past three years , 12% over the past five years .